Chiral analysis: finding D-amino acid impurities

Every amino acid except glycine exists in two mirror-image forms, L and D. A synthetic peptide is meant to have a defined configuration at each position, usually all L, sometimes with D-residues by design. A residue in the wrong form gives a diastereomer: same sequence, same mass, different shape. This article explains where wrong-configuration residues come from, why the usual identity and purity tests can miss them, and how chiral analysis measures them.

Where D-impurities come from

During peptide synthesis, each amino acid is chemically activated so that it couples to the growing chain. Activation can also remove the proton at the α-carbon for a moment, and when it returns it can approach from either side: the residue racemizes. Cysteine and histidine are the most prone; elevated temperatures, strong bases and some coupling conditions increase the risk. Aspartic acid can also epimerize through the aspartimide ring.

Each step usually racemizes only a fraction of a percent, but a long synthesis has many steps, and the impurities add up across positions.

Why routine tests miss them

• Mass spectrometry sees the same mass for a diastereomer as for the intended peptide, and the same fragments.
• HPLC often separates diastereomers, because a single changed configuration alters how the peptide folds and binds the column, but not always: some elute under or as a shoulder on the main peak.
• Amino acid analysis counts D- and L-forms together, and its own acid hydrolysis racemizes a little of every residue.

How chiral analysis works

The standard approach takes the peptide apart and measures each amino acid's D/L ratio:

1. Hydrolysis in deuterated acid. The peptide is hydrolyzed in DCl in D₂O. Any residue that racemizes during hydrolysis picks up a deuterium at its α-carbon and becomes 1 Da heavier, so mass spectrometry can tell hydrolysis-made D-forms from those that were in the peptide before.
2. Separation of enantiomers, either directly on a chiral stationary phase (gas chromatography after derivatization, or chiral HPLC), or after reaction with a chiral reagent such as Marfey's reagent (1-fluoro-2,4-dinitrophenyl-5-L-alanine amide), which turns each pair of enantiomers into diastereomers that an ordinary reversed-phase column separates.
3. Detection and calculation of the D-content for each amino acid, counting only the unlabeled (original) D-forms.

The result is a D-content per amino acid, often reported as a percentage, for example "D-His 0.4%". For a peptide with D-residues by design, the same analysis confirms that the intended positions are D and the others are not.

An intact-peptide approach complements it: an HPLC method developed to resolve the diastereomers of the specific sequence, sometimes checked against deliberately made diastereomer standards.

Reading a result

• A chiral result is reported per amino acid, not per position; if a residue appears several times, the analysis cannot say which copy is affected.
• Low single-digit percentages for His or Cys are not unusual in synthetic peptides; the acceptable level depends on the experiment.
• Results without deuterium correction overstate the D-content, because hydrolysis itself creates some.

Frequently asked questions

Is chiral analysis part of a standard certificate?

Usually not for research peptides. It is a specialized test, run when stereochemical purity matters to the experiment or when a residue is known to be prone to racemization.

Can a peptide with D-residues by design be checked the same way?

Yes. The D/L ratio of each amino acid is compared with what the sequence specifies.

Why not just look for a second peak in HPLC?

Some diastereomers separate well, but others co-elute with the main peak. A chiral analysis measures the D-content regardless of whether the HPLC method resolves it.

Sources & Further Reading

1. Liardon R, Ledermann S, Ott U. Determination of D-amino acids by deuterium labeling and selected ion monitoring. Journal of Chromatography A 1981;203:385–395. doi:10.1016/S0021-9673(00)80309-X
2. Marfey P. Determination of D-amino acids. II. Use of a bifunctional reagent, 1,5-difluoro-2,4-dinitrobenzene. Carlsberg Research Communications 1984;49(6):591–596. doi:10.1007/BF02908688
3. Bhushan R, Brückner H. Marfey's reagent for chiral amino acid analysis: a review. Amino Acids 2004;27(3–4):231–247. doi:10.1007/s00726-004-0118-0
4. Frank H, Nicholson GJ, Bayer E. Rapid gas chromatographic separation of amino acid enantiomers with a novel chiral stationary phase. Journal of Chromatographic Science 1977;15(5):174–176. doi:10.1093/chromsci/15.5.174
5. Palasek SA, Cox ZJ, Collins JM. Limiting racemization and aspartimide formation in microwave-enhanced Fmoc solid phase peptide synthesis. Journal of Peptide Science 2007;13(3):143–148. doi:10.1002/psc.804

Cosmic Peptides. (2026, October 25). Chiral analysis: finding D-amino acid impurities. Cosmic Peptides Research Library. Retrieved October 26, 2026, from https://cosmicpeptides.com/research/methods/chiral-analysis

@misc{cosmicpeptides_research_methods_chiral_analysis,
  author       = {{Cosmic Peptides}},
  title        = {Chiral analysis: finding D-amino acid impurities},
  howpublished = {Cosmic Peptides Research Library},
  year         = {2026},
  month        = oct,
  url          = {https://cosmicpeptides.com/research/methods/chiral-analysis},
  urldate      = {2026-10-26},
  note         = {Last reviewed 2026-10-25}
}

TY  - ELEC
AU  - Cosmic Peptides
TI  - Chiral analysis: finding D-amino acid impurities
T2  - Cosmic Peptides Research Library
PB  - Cosmic Peptides
PY  - 2026
DA  - 2026/10/25
UR  - https://cosmicpeptides.com/research/methods/chiral-analysis
Y2  - 2026/10/26
LA  - en
ER  -